House Positions for C:APHA from 20190220 to 20190220

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
39 Merrill Lynch	505,685	6,594,449	13.041	281,099	3,662,705	13.03	224,586	-2,931,744
79 CIBC	2,223,500	28,921,964	13.007	2,038,065	26,542,064	13.023	185,435	-2,379,900
85 Scotia	457,379	5,966,395	13.045	381,683	4,979,341	13.046	75,696	-987,054
90 Barclays	38,500	502,734	13.058	3,500	45,696	13.056	35,000	-457,038
13 Instinet	148,363	1,924,493	12.972	131,500	1,703,957	12.958	16,863	-220,536
57 Interactive	4,690	61,315	13.074	2,160	28,233	13.071	2,530	-33,082
70 Manulife	2,152	28,426	13.209	360	4,712	13.089	1,792	-23,714
28 BBS	2,812	36,681	13.044	1,202	15,776	13.125	1,610	-20,905
48 Laurentian	1,000	13,130	13.13	0			1,000	-13,130
33 Canaccord	548	7,156	13.058	0			548	-7,156
89 Raymond James	500	6,550	13.10	0			500	-6,550
22 Fidelity	400	5,224	13.06	0			400	-5,224
36 Latimer	4,622	60,246	13.035	4,508	58,730	13.028	114	-1,516
68 Leede	200	2,646	13.23	200	2,636	13.18	0	-10
65 Goldman	300	3,885	12.95	500	6,516	13.032	-200	2,631
62 Haywood	0			250	3,250	13.00	-250	3,250
76 Industrial Alliance	380	4,974	13.089	2,100	27,247	12.975	-1,720	22,273
56 Edward Jones	391	5,120	13.095	2,400	31,444	13.102	-2,009	26,324
99 Jitney	135,700	1,764,160	13.00	137,800	1,794,888	13.025	-2,100	30,728
88 Credential	67,390	881,187	13.076	72,324	947,774	13.105	-4,934	66,587
14 ITG	1,200	15,692	13.077	6,520	85,942	13.181	-5,320	70,250
101 SG Capital	2,950	38,214	12.954	9,950	130,013	13.067	-7,000	91,799
143 Pershing	13,905	180,376	12.972	21,750	279,719	12.861	-7,845	99,343
124 Questrade	91,311	1,188,928	13.021	106,927	1,395,057	13.047	-15,616	206,129
80 National Bank	112,044	1,456,942	13.003	128,153	1,667,719	13.013	-16,109	210,777
53 Morgan Stanley	1,515	19,594	12.933	17,986	234,026	13.012	-16,471	214,432
1 Anonymous	1,428,240	18,582,946	13.011	1,454,943	18,919,990	13.004	-26,703	337,044
19 Desjardins	45,125	587,878	13.028	101,933	1,331,550	13.063	-56,808	743,672
7 TD Sec	1,267,218	16,526,232	13.041	1,383,877	18,026,396	13.026	-116,659	1,500,164
2 RBC	407,012	5,307,208	13.039	533,947	6,964,061	13.043	-126,935	1,656,853
9 BMO Nesbitt	108,958	1,424,719	13.076	248,353	3,230,022	13.006	-139,395	1,805,303
TOTAL	7,073,990	92,119,464	13.022	7,073,990	92,119,464	13.022	0	0

Aphria announces early termination and liquidation of interests in Liberty Health Sciences, Inc.

News for APHA

Alert Sent 2019-02-19 06:29:16 PM ET

Delivery preference: Immediate delivery

Aphria announces early termination and liquidation of interests in Liberty Health Sciences, Inc.

2019-02-19 06:28:00 PM ET (CNW Group)


Cash proceeds of $47 million received, with additional $10 million upon satisfaction of certain conditions


Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE:APHA) today announced that independent members of its Board of Directors consisting of Shlomo Bibas, John Herhalt, Tom Looney and Irwin Simon, unanimously approved the early termination and liquidation of a promissory note, option and other agreements (the "Early Termination and Liquidation") related to the Company's previously announced divestment of all interests in Liberty Health Sciences, Inc. ("Liberty").


As detailed on September 6, 2018, the Company entered into a share purchase agreement with a group of buyers, wherein it completed the sale of the shares making up 100% of its outstanding interest in Liberty, in exchange for a five-year promissory note due September 6, 2023, bearing interest at 12% per annum and in the amount of $59,097,986. Aphria retained an irrevocable option to repurchase its shares in Liberty from the buyers for a period of up to five years, subject to the satisfaction of certain conditions.


In line with Aphria's commitment to enhanced corporate governance practices and a renewed focus on its strategic plan, the option in the Liberty shares represented a non-essential holding of the Company. Accordingly, the independent members of the Board of Directors unanimously approved the Early Termination  and Liquidation  wherein the Company received  cash  consideration (the "Consideration") of $47.4 million and may earn up to an additional $10 million based on certain value thresholds, if the counterparties monetize the Liberty shares underlying the terminated option within six months. Jefferies LLC acted as financial advisor to the Company.


The Early Termination and Liquidation represents the ultimate conclusion of Aphria's investment in Liberty. From Aphria's first investment in Liberty of $25 million in April 2017 until today's date, Aphria earned a return equal to 3.4 times its cumulative investment in Liberty, an internal rate of return of approximately 167.2% on the initial investment.


We Have A Good Thing Growing


About Aphria